We recently published a list of 10 Best Medical Stocks to Buy Now. In this article, we are going to take a look at where ...

We recently published a list of 10 Best Healthcare ... growth driver in the cardiometabolic space. Merck & Co., (NYSE:MRK)’s new pneumococcal vaccine for adults received FDA approval, marking ...

Merck is immune from an antitrust lawsuit accusing it of misleading regulators about the effectiveness of its mumps vaccine ...

Merck & Co. has picked up options on two Evaxion Biotech vaccine candidates, paying $3.2 million and dangling more than $1 billion in milestones for the chance to pick up preclinical prospects ...

We recently compiled a list of the 8 Most Undervalued Value Stocks To Buy According To Analysts. In this article, we are ...

That list includes eight serotypes not included in any currently licensed pneumococcal vaccine, said Merck, which reported the results today at the International Symposium on Pneumococci and ...

is scheduled to review both the two new vaccines and decide how they should be used in adults, according to Merck. Prevnar 20 has now been launched at a list price of $232, roughly in line with ...

Merck’s ongoing pneumococcal vaccine development program is designed to provide options that address the specific needs of different populations, including infants and children, healthy adults ...

Merck & Co. escaped antitrust claims by a group physicians who alleged that they bought the company’s mumps vaccine at inflated prices because it deceived the government to maintain its monopoly on ...

Merck (NYSE:MRK) announced Wednesday that its 21-valent pneumococcal vaccine, Capvaxive, approved in the U.S. to prevent pneumonia, generated positive immune responses in a Phase 3 trial for ...

We recently published a list of 10 Best Medical Stocks to ... The company benefited from rapid international launches. Merck’s new pneumococcal vaccine, CAPVAXIVE, received FDA approval and ...

We recently published a list of 10 Best Healthcare ... and sells prescription medicines, vaccines, and animal health products. At its core, Merck is in the business of improving human and animal ...